Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (365)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lowe, S. W.
Right arrow Articles by Lin, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lowe, S. W.
Right arrow Articles by Lin, A. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 21, No. 3, 485-495, March 2000
© 2000 Oxford University Press


Cancer Biology

Apoptosis in cancer

Scott W. Lowe1 and Athena W. Lin

Cold Spring Harbor Laboratory, 1 Bungtown Road, PO Box 100, Cold Spring Harbor, New York, NY 11724, USA

In the last decade, basic cancer research has produced remarkable advances in our understanding of cancer biology and cancer genetics. Among the most important of these advances is the realization that apoptosis and the genes that control it have a profound effect on the malignant phenotype. For example, it is now clear that some oncogenic mutations disrupt apoptosis, leading to tumor initiation, progression or metastasis. Conversely, compelling evidence indicates that other oncogenic changes promote apoptosis, thereby producing selective pressure to override apoptosis during multistage carcinogenesis. Finally, it is now well documented that most cytotoxic anticancer agents induce apoptosis, raising the intriguing possibility that defects in apoptotic programs contribute to treatment failure. Because the same mutations that suppress apoptosis during tumor development also reduce treatment sensitivity, apoptosis provides a conceptual framework to link cancer genetics with cancer therapy. An intense research effort is uncovering the underlying mechanisms of apoptosis such that, in the next decade, one envisions that this information will produce new strategies to exploit apoptosis for therapeutic benefit.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
L. Shkreta, U. Froehlich, E. R. Paquet, J. Toutant, S. A. Elela, and B. Chabot
Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes
Mol. Cancer Ther., June 1, 2008; 7(6): 1398 - 1409.
[Abstract] [Full Text] [PDF]


Home page
Bioscience HorizonsHome page
H. Angell
A study into the potential role of Survivin localization in resistance to drug-induced apoptosis
Bioscience Horizons, June 1, 2008; 1(2): 85 - 91.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wang, A. T. C. Lee, J. Z. I. Ma, J. Wang, J. Ren, Y. Yang, E. Tantoso, K.-B. Li, L. L. P. J Ooi, P. Tan, et al.
Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target
J. Biol. Chem., May 9, 2008; 283(19): 13205 - 13215.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
O. Fromigue, Z. Hamidouche, and P. J. Marie
Statin-Induced Inhibition of 3-Hydroxy-3-Methyl Glutaryl Coenzyme A Reductase Sensitizes Human Osteosarcoma Cells to Anticancer Drugs
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 595 - 600.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
R. Mazroui, S. Di Marco, E. Clair, C. von Roretz, S. A. Tenenbaum, J. D. Keene, M. Saleh, and I.-E. Gallouzi
Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis
J. Cell Biol., January 10, 2008; 180(1): 113 - 127.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Liu, Z.-G. Lu, Y. Miki, and K. Yoshida
Protein Kinase C {delta} Induces Transcription of the TP53 Tumor Suppressor Gene by Controlling Death-Promoting Factor Btf in the Apoptotic Response to DNA Damage
Mol. Cell. Biol., December 15, 2007; 27(24): 8480 - 8491.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Drakos, A. Thomaides, L. J. Medeiros, J. Li, V. Leventaki, M. Konopleva, M. Andreeff, and G. Z. Rassidakis
Inhibition of p53-Murine Double Minute 2 Interaction by Nutlin-3A Stabilizes p53 and Induces Cell Cycle Arrest and Apoptosis in Hodgkin Lymphoma
Clin. Cancer Res., June 1, 2007; 13(11): 3380 - 3387.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Zhang, T. Sun, L. Xue, X. Han, B. Zhang, N. Lu, Y. Shi, W. Tan, Y. Zhou, D. Zhao, et al.
Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer
Carcinogenesis, May 1, 2007; 28(5): 1067 - 1073.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. E. Manjarrez, R. Ocadiz, L. Valle, C. Pacheco, A. Marroquin, C. De la Torre, M. Selman, and P. Gariglio
Detection of Human Papillomavirus and Relevant Tumor Suppressors and Oncoproteins in Laryngeal Tumors
Clin. Cancer Res., December 1, 2006; 12(23): 6946 - 6951.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Fikaris, A. E. Lewis, A. Abulaiti, O. M. Tsygankova, and J. L. Meinkoth
Ras Triggers Ataxia-telangiectasia-mutated and Rad-3-related Activation and Apoptosis through Sustained Mitogenic Signaling
J. Biol. Chem., November 17, 2006; 281(46): 34759 - 34767.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. Tomiyama, S. Serizawa, K. Tachibana, K. Sakurada, H. Samejima, Y. Kuchino, and C. Kitanaka
Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors bax and bak.
J Natl Cancer Inst, October 18, 2006; 98(20): 1462 - 1473.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. M. Chin and R. Herbst
Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
Mol. Cancer Ther., October 1, 2006; 5(10): 2580 - 2591.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Veluri, R. P. Singh, Z. Liu, J. A. Thompson, R. Agarwal, and C. Agarwal
Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells
Carcinogenesis, July 1, 2006; 27(7): 1445 - 1453.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J.-M. Yun, M.-H. Kweon, H. Kwon, J.-K. Hwang, and H. Mukhtar
Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145
Carcinogenesis, July 1, 2006; 27(7): 1454 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J. Y. Park, J. M. Park, J. S. Jang, J. E. Choi, K. M. Kim, S. I. Cha, C. H. Kim, Y. M. Kang, W. K. Lee, S. Kam, et al.
Caspase 9 promoter polymorphisms and risk of primary lung cancer
Hum. Mol. Genet., June 15, 2006; 15(12): 1963 - 1971.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Humphries, K. H. Limesand, J. C. Schneider, K. I. Nakayama, S. M. Anderson, and M. E. Reyland
Suppression of Apoptosis in the Protein Kinase C{delta} Null Mouse in Vivo
J. Biol. Chem., April 7, 2006; 281(14): 9728 - 9737.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. S. Dharap, P. Chandna, Y. Wang, J. J. Khandare, B. Qiu, S. Stein, and T. Minko
Molecular Targeting of BCL2 and BCLXL Proteins by Synthetic BCL2 Homology 3 Domain Peptide Enhances the Efficacy of Chemotherapy
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 992 - 998.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. T. Schafer, A. B. Parrish, K. M. Wright, S. S. Margolis, J. R. Marks, M. Deshmukh, and S. Kornbluth
Enhanced Sensitivity to Cytochrome c-Induced Apoptosis Mediated by PHAPI in Breast Cancer Cells
Cancer Res., February 15, 2006; 66(4): 2210 - 2218.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Belkhiri, A. Zaika, N. Pidkovka, S. Knuutila, C. Moskaluk, and W. El-Rifai
Darpp-32: a Novel Antiapoptotic Gene in Upper Gastrointestinal Carcinomas
Cancer Res., August 1, 2005; 65(15): 6583 - 6592.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
X Zhang, X Miao, T Sun, W Tan, S Qu, P Xiong, Y Zhou, and D Lin
Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer
J. Med. Genet., June 1, 2005; 42(6): 479 - 484.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
I. M. Ghobrial, T. E. Witzig, and A. A. Adjei
Targeting Apoptosis Pathways in Cancer Therapy
CA Cancer J Clin, May 1, 2005; 55(3): 178 - 194.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Cozzolino, P. Palladino, F. Rossi, G. Cali, E. Benedetti, and P. Laccetti
Antineoplastic cyclic astin analogues kill tumour cells via caspase-mediated induction of apoptosis
Carcinogenesis, April 1, 2005; 26(4): 733 - 739.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Yim, R. P. Singh, C. Agarwal, S. Lee, H. Chi, and R. Agarwal
A Novel Anticancer Agent, Decursin, Induces G1 Arrest and Apoptosis in Human Prostate Carcinoma Cells
Cancer Res., February 1, 2005; 65(3): 1035 - 1044.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Wang, M. Cuddy, T. Samuel, K. Welsh, A. Schimmer, F. Hanaii, R. Houghten, C. Pinilla, and J. C. Reed
Cellular, Biochemical, and Genetic Analysis of Mechanism of Small Molecule IAP Inhibitors
J. Biol. Chem., November 12, 2004; 279(46): 48168 - 48176.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Kondoh, I. Suzuki, M. Sato, F. Nagashima, S. Simizu, M. Harada, M. Fujii, H. Osada, Y. Asakawa, and Y. Watanabe
Kaurene Diterpene Induces Apoptosis in Human Leukemia Cells Partly through a Caspase-8-Dependent Pathway
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 115 - 122.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Tyagi, C. Agarwal, G. Harrison, L. M. Glode, and R. Agarwal
Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages
Carcinogenesis, September 1, 2004; 25(9): 1711 - 1720.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Trompier, X.-B. Chang, R. Barattin, A. d. M. d'Hardemare, A. Di Pietro, and H. Baubichon-Cortay
Verapamil and Its Derivative Trigger Apoptosis through Glutathione Extrusion by Multidrug Resistance Protein MRP1
Cancer Res., July 15, 2004; 64(14): 4950 - 4956.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
T. Sun, X. Miao, X. Zhang, W. Tan, P. Xiong, and D. Lin
Polymorphisms of Death Pathway Genes FAS and FASL in Esophageal Squamous-Cell Carcinoma
J Natl Cancer Inst, July 7, 2004; 96(13): 1030 - 1036.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-T. Lin, C.-C. Chang, S.-T. Chen, H.-L. Chang, J.-L. Su, Y.-P. Chau, and M.-L. Kuo
Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-{kappa}B-dependent XIAP Up-Regulation
J. Biol. Chem., June 4, 2004; 279(23): 24015 - 24023.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Staalesen, B. Leirvaag, J. R. Lillehaug, and P. E. Lonning
Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer
Clin. Cancer Res., May 15, 2004; 10(10): 3438 - 3443.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Karlsson, I. Ora, I. Porn-Ares, and S. Pahlman
Arsenic Trioxide-Induced Death of Neuroblastoma Cells Involves Activation of Bax and Does Not Require p53
Clin. Cancer Res., May 1, 2004; 10(9): 3179 - 3188.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. D. Albright, R. I. Salganik, and T. Van Dyke
Dietary Depletion of Vitamin E and Vitamin A Inhibits Mammary Tumor Growth and Metastasis in Transgenic Mice
J. Nutr., May 1, 2004; 134(5): 1139 - 1144.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. C. Han, M.-Y. Lee, K. D. Shin, S. B. Jeon, J. M. Kim, K.-H. Son, H.-C. Kim, H.-M. Kim, and B.-M. Kwon
2'-Benzoyloxycinnamaldehyde Induces Apoptosis in Human Carcinoma via Reactive Oxygen Species
J. Biol. Chem., February 20, 2004; 279(8): 6911 - 6920.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Fulda and K.-M. Debatin
Sensitization for Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by the Chemopreventive Agent Resveratrol
Cancer Res., January 1, 2004; 64(1): 337 - 346.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. P. Singh, G. Sharma, G. U. Mallikarjuna, S. Dhanalakshmi, C. Agarwal, and R. Agarwal
In Vivo Suppression of Hormone-Refractory Prostate Cancer Growth by Inositol Hexaphosphate: Induction of Insulin-Like Growth Factor Binding Protein-3 and Inhibition of Vascular Endothelial Growth Factor
Clin. Cancer Res., January 1, 2004; 10(1): 244 - 250.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Pingoud-Meier, D. Lang, A. J. Janss, L. B. Rorke, P. C. Phillips, T. Shalaby, and M. A. Grotzer
Loss of Caspase-8 Protein Expression Correlates with Unfavorable Survival Outcome in Childhood Medulloblastoma
Clin. Cancer Res., December 15, 2003; 9(17): 6401 - 6409.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. S. Allal, L. Waelchli, and M.-A. Brundler
Prognostic Value of Apoptosis-Regulating Protein Expression in Anal Squamous Cell Carcinoma
Clin. Cancer Res., December 15, 2003; 9(17): 6489 - 6496.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. A. Nguewa, M. A. Fuertes, C. Alonso, and J. M. Perez
Pharmacological Modulation of Poly(ADP-ribose) Polymerase-Mediated Cell Death: Exploitation in Cancer Chemotherapy
Mol. Pharmacol., November 1, 2003; 64(5): 1007 - 1014.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Ortega, P. Ferrer, J. Carretero, E. Obrador, M. Asensi, J. A. Pellicer, and J. M. Estrela
Down-regulation of Glutathione and Bcl-2 Synthesis in Mouse B16 Melanoma Cells Avoids Their Survival during Interaction with the Vascular Endothelium
J. Biol. Chem., October 10, 2003; 278(41): 39591 - 39599.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Vos, C. A. Ellis, C. Elam, A. S. Ulku, B. J. Taylor, and G. J. Clark
RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor Suppressor
J. Biol. Chem., July 18, 2003; 278(30): 28045 - 28051.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Misra, S. Ghatak, A. Zoltan-Jones, and B. P. Toole
Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan
J. Biol. Chem., July 3, 2003; 278(28): 25285 - 25288.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. T. Nguyen and J. A. Wells
Direct activation of the apoptosis machinery as a mechanism to target cancer cells
PNAS, June 24, 2003; 100(13): 7533 - 7538.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. Shimoda, W. E. Achanzar, W. Qu, T. Nagamine, H. Takagi, M. Mori, and M. P. Waalkes
Metallothionein Is a Potential Negative Regulator of Apoptosis
Toxicol. Sci., June 1, 2003; 73(2): 294 - 300.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. M. Tidd, C. M. Broughton, and R. E. Clark
CpG oligodeoxynucleotide 5mer-induced apoptosis in MOLT-4 leukaemia cells does not require caspase 3 or new protein synthesis
Nucleic Acids Res., May 1, 2003; 31(9): 2297 - 2304.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. P. Singh, C. Agarwal, and R. Agarwal
Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes
Carcinogenesis, March 1, 2003; 24(3): 555 - 563.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y. Li, J. M. Wo, L. Cai, Z. Zhou, D. Rosenbaum, C. Mendez, M. B. Ray, W. F. Jones, and Y. J. Kang
Association of Metallothionein Expression and Lack of Apoptosis with Progression of Carcinogenesis in Barrett's Esophagus
Experimental Biology and Medicine, March 1, 2003; 228(3): 286 - 292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Li, T. Takasu, D. M. Perlman, M. S. Peterson, D. Burrichter, S. Avdulov, P. B. Bitterman, and V. A. Polunovsky
Translation Factor eIF4E Rescues Cells from Myc-dependent Apoptosis by Inhibiting Cytochrome c Release
J. Biol. Chem., January 24, 2003; 278(5): 3015 - 3022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. R. Mercatante, J. L. Mohler, and R. Kole
Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents
J. Biol. Chem., December 13, 2002; 277(51): 49374 - 49382.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Ansah and N. J. Gooderham
The Popular Herbal Antimalarial, Extract of Cryptolepis sanguinolenta, Is Potently Cytotoxic
Toxicol. Sci., December 1, 2002; 70(2): 245 - 251.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Agarwal, R. P. Singh, and R. Agarwal
Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release
Carcinogenesis, November 1, 2002; 23(11): 1869 - 1876.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. K. Tyagi, R. P. Singh, C. Agarwal, D. C. F. Chan, and R. Agarwal
Silibinin Strongly Synergizes Human Prostate Carcinoma DU145 Cells to Doxorubicin-induced Growth Inhibition, G2-M Arrest, and Apoptosis
Clin. Cancer Res., November 1, 2002; 8(11): 3512 - 3519.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Belhocine, N. Steinmetz, R. Hustinx, P. Bartsch, G. Jerusalem, L. Seidel, P. Rigo, and A. Green
Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis
Clin. Cancer Res., September 1, 2002; 8(9): 2766 - 2774.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. G. Ferreira, M. Epping, F. A. E. Kruyt, and G. Giaccone
Apoptosis: Target of Cancer Therapy
Clin. Cancer Res., July 1, 2002; 8(7): 2024 - 2034.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Zhang, J. Li, L. E. Lantry, Y. Wang, R. W. Wiseman, R. A. Lubet, and M. You
p53 Transgenic Mice Are Highly Susceptible to 1, 2-Dimethylhydrazine-induced Uterine Sarcomas
Cancer Res., June 1, 2002; 62(11): 3024 - 3029.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P.-F. Cartron, L. Oliver, S. Martin, C. Moreau, M.-T. LeCabellec, P. Jezequel, K. Meflah, and F. M. Vallette
The expression of a new variant of the pro-apoptotic molecule Bax, Bax{psi}, is correlated with an increased survival of glioblastoma multiforme patients
Hum. Mol. Genet., March 1, 2002; 11(6): 675 - 687.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. P. Singh, A. K. Tyagi, J. Zhao, and R. Agarwal
Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis
Carcinogenesis, March 1, 2002; 23(3): 499 - 510.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Shureiqi, W. Jiang, S. M. Fischer, X. Xu, D. Chen, J. J. Lee, R. Lotan, and S. M. Lippman
GATA-6 Transcriptional Regulation of 15-Lipoxygenase-1 during NSAID-induced Apoptosis in Colorectal Cancer Cells
Cancer Res., February 1, 2002; 62(4): 1178 - 1183.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. M. Lippman and W. Ki Hong
Cancer Prevention by Delay : Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002.
Clin. Cancer Res., February 1, 2002; 8(2): 305 - 313.
[Full Text]